CAPRICOR THERAPEUTICS |
USA |
Gesundheit |
US14070B3096 / A2PLU4 |
4LN2 (Frankfurt) / CAPR (NASDAQ) |
FRA:4LN2, ETR:4LN2, 4LN2:GR, NASDAQ:CAPR |
- |
https://capricor.com/ |
Capricor Therapeutics Inc. is a biotechnology comp..
>Volltext.. |
246.88 Mio. EUR |
146.38 Mio. EUR |
11.39 Mio. EUR |
-61.04 Mio. EUR |
-59.51 Mio. EUR |
-1.4 EUR |
3.76 Mio. EUR |
19.77 Mio. EUR |
-45.07 Mio. EUR |
4.32 |
-55.15% |
-127.68% |
- |
- |
- |
- |
CAPRICOR THERAPEUTICS, CAPRICOR THERAPEUTIC |
09.09.25 |
|